About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
AMRN - Amarin Corporation p...| Previous Close | $6.55 | Open | |
| Volume | 1K | Market Cap | 2.462B |
| Yield | Last Dividend |
| The Daily Biotech Pulse: Fluidigm's Sali... | 01/22/21 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 21) Aca... | |
| Stifel Nicolaus Stick to Their Hold Rati... | 01/21/21 |
| Stifel Nicolaus Stick to Their Hold Rating for Amarin Corporation Plc | |
| Amarin Provides Preliminary 2020 Results... | 01/07/21 |
| Unaudited 2020 Total Net Revenue Estimated to Be Approximately $610 Million, an Increase of Approximately 42% Compared with 2019 Completion of Europea... | |
| Amarin Highlights Multiple VASCEPA?? (Ic... | 12/14/20 |
| REDUCE-IT?? EPA Encore Presentation reinforces Eicosapentaenoic Acid (EPA) levels from VASCEPA?? (icosapent ethyl) strongly correlated to cardiovascul... | |
| Powerful ICE: Sunday, Dec 13, 2020 (ALXN... | 12/13/20 |
| What if I tell you that you don't need to know it all to succeed in biotech? Now, I don't mean just sitting there doing nothing. And, I don't mean you... | |
| Amarin Reports Encouraging Efficacy and ... | 12/12/20 |
| VASCEPA COVID-19 CardioLink-9 Randomized Trial suggests improvement in patient-reported COVID-19 symptoms while achieving its primary endpoint by ??? | |
| Amarin Corporation plc (AMRN) CEO John T... | 12/02/20 |
| Amarin Corporation plc (NASDAQ:AMRN) Piper Sandler 32nd Annual Virtual Healthcare Conference Dec 02, 2020, 10:00 AM ET Company Participants John Thero... | |
| AstraZeneca ??? Nov 22, 2020 ??? Eversep... | 11/22/20 |
| AstraZeneca - Nov 22, 2020 - Eversept Companions, LLC Buys Amarin Corp PLC, Teva Pharmaceutical Industries, Catalent Inc, Sells TG Therapeutics Inc, A... | |
| Amarin Jumps on Heart-Drug Progress in C... | 11/20/20 |
| Amarin's cardiovascular-disease treatment Vascepa met its key endpoint in a late-stage trial in China. | |
| The Daily Biotech Pulse: Amarin Surges O... | 11/20/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Nov. 19) ??? | |
| Amarin Corporation plc (AMRN) Q3 2020 Ea... | 11/05/20 |
| Amarin Corporation plc (NASDAQ: AMRN) Q3 2020 earnings call dated Nov. 05, 2020 | |
| Amarin (NASDAQ:AMRN) Shares Up 6.4% | 10/22/20 |
| Shares of Amarin Co. plc (NASDAQ:AMRN) rose 6.4% during mid-day trading on Thursday . The company traded as high as $5.13 and last traded at $5.02. Ap... | |
| FXNEWS24 |BUZZ-U.S. STOCKS ON THE MOVE-P... | 10/17/20 |
| BUZZ-U.S. STOCKS ON THE MOVE-Pfizer, Hewlett Packard, BioNTech, Amarin | UK Stocks, Forex, Commodities, Crypto, Live Market News- Daily Forex News | |
| Looking Into Amarin Corp's Return On Cap... | 10/16/20 |
| Looking at Q2, Amarin Corp (NASDAQ: AMRN) earned $4.16 million, a 117.3% increase from the preceding quarter. Amarin Corp's sales decreased to $135.32... | |
| Unusual Options Activity Insight: Amarin... | 10/06/20 |
| On Tuesday, shares of Amarin Corp (NASDAQ: AMRN) saw unusual options activity. After the option alert, the stock price moved down to $5.01. Sentiment:... | |
| ROCE Insights For Amarin Corp | 10/05/20 |
| Amarin Corp (NASDAQ: AMRN) posted Q2 earnings of $4.16 million, an increase from Q1 of 117.3%. Sales dropped to $135.32 million, a 12.69% decrease bet... | |
| Amarin (AMRN) Investor Presentation - Sl... | 09/16/20 |
| The following slide deck was published by Amarin Corporation plc in conjunction with this event. | |
| Amarin Corporation plc (AMRN) CEO John T... | 09/16/20 |
| Amarin Corporation plc (NASDAQ:AMRN) Cantor Virtual Global Healthcare Conference Call September 16, 2020 11:20 A.M. | |
| Amarin (AMRN): Vascepa???s International... | 09/11/20 |
| The markets might be in turmoil, but spare a thought for the current woes at biotech Amarin (AMRN). Over the past 7 trading sessions, shares have retr... | |
| Amarin: 'The Future Ain't What It Used T... | 09/08/20 |
| Once the darling of analysts and investors, Amarin has run into a spate of problems. With one approved drug, nothing in the pipeline, and a value chai... | |
| Amarin Is A Good Contrarian Pick To Cons... | 09/06/20 |
| Amarin shares have taken a beating this week during the appellate hearing and especially after the adverse ruling came down on September 3. | |
| The Week Ahead In Biotech: Focus On Mall... | 09/06/20 |
| After remaining steady in the first three sessions of the week ended Sept. 4, biotech stocks pulled back along with the broader market in a tech-induc... | |
| Amarin Shares Sink As Generic Competitio... | 09/04/20 |
| The air keeps leaking out of Amarin, a once-hot stock that captured the imaginations of investors with a proprietary fish oil-derived heart drug. | |
| Fed Circuit swiftly rejects Amarin bid t... | 09/03/20 |
| A federal appeals court on Thursday dealt a major setback to pharmaceutical company Amarin Corp, affirming a patent ruling that opened the door to gen... | |
| Amarin Loses Appeal in Heart Treatment P... | 09/03/20 |
| The U.S. Court of Appeals makes its ruling one day after hearing arguments in the case. | |
| Amarin Provides Update Following Ruling ... | 09/03/20 |
| DUBLIN, Ireland and BRIDGEWATER, N.J., Sept. 03, 2020 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today provided an update following the?... | |
| Amarin loses appeal over heart drug pate... | 09/03/20 |
| Amarin failed to convince an appeals court to revive key patents covering its heart drug Vascepa, exposing the drug to generic competition in the U.S. | |
| 5 Top Stock Trades for Thursday: PTON, D... | 09/02/20 |
| Peloton, Docusign, MongoDB, Amarin and SmileDirectClub were our top stock trades for Thursday. So, let's take a closer look at the charts. | |
| Amarin Shares Off - Analysts Mull Prospe... | 09/02/20 |
| Amarin shares are lower after analysts assessed how the judges in the company's patent-case appeal might rule. | |
| Amarin plummets 31% after appeal hearing... | 09/02/20 |
| Summary List Placement Amarin plummeted as much as 31% after its appeal hearing related to invalidated patents for its key drug was "incrementally neg... | |
| Date | 2020-11-05 (BMO) | Est. (EPS/Rev.) | $0.01/ 154.63M |
| Actual (EPS/Rev.) | $-0.02/ $156.50 M | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| FEAT. ANDRE 3000 | JOHN KROLIKOWSKI JR | 89.00 % | Subscribe |
| Big Data Zhou | Zhou Academy | 82.00 % | Subscribe |
| Options Eagle | George | 79.00 % | Follow |
| Alpha Swing Trades | Jonathan | 68.00 % | Follow |
| Option short-term trading [Unusual] | Debashis K | 66.00 % | Subscribe |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
